Severity of Covid-19 Clinical Outcomes and Mortality in Multiple Myeloma Patients over Year 1 of the Pandemic

Introduction In the first weeks of the Covid-19 pandemic when healthcare systems in many areas were overstretched, we documented that hospital mortality in multiple myeloma (MM) patients infected by Sars-Cov-2 was 50% higher than in age matched Covid-19 patients without cancer. In the following mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-López, Joaquín, Mateos, Maria-Victoria, López-Muñoz, Nieves, Senin Magan, Maria Alicia, De Miguel, Maria Dunia, López de la Guía, Ana, Sureda, Anna, Encinas, Cristina, Conde Royo, Diego, Rosinol, Laura, García Tomás, Lucía, Hernandez-Rivas, Jose Angel, Alberto Rojas, Javier, Alegre, Adrian, Blanchard, María Jesús, Escalante Barrigón, Fernando, Garcia, Esther González, Iñigo, Belén, Bravo Barahona, Pilar, Penalver, F. Javier, De La Rubia, Javier, Fernandez-Escalada, Noemi, Alonso Alonso, Jose Maria, Bladé, Joan, Lahuerta, Juan Jose, De La Cruz, Javier, San-Miguel, Jesús F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
652.Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701769/
http://dx.doi.org/10.1182/blood-2021-149192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701769/
http://dx.doi.org/10.1182/blood-2021-149192

Ejemplares similares